relapsed

Three cases relapsed because their PML/ RAR α fusion genes changed from negative to positive.

3例PML/RARα融合基因由阴性转为阳性后复发。

[ Purpose] To investigate the effect of VID regimen ( IFO, VM26, DXM) for the treatment of relapsed or refractory lymphoma.

[目的]探讨用异环磷酰胺（IFO）、威猛（VM26）、地塞米松（DXM，VID方案）治疗复发性难治性恶性淋巴瘤疗效。

Methods Fifteen patients with stage ⅲ A relapsed/ refractory MM were treated by ATO ( 10 mg/ d) and Vit C ( 2 g/ d) lasting 7-14 d every month for 4-6 cycles.

方法：15例ⅢA期难治复发MM患者，应用ATO（10mg/d）联合Vit C（2g/d），连用7～14d，每月1次，4～6个周期。